Announcements Trials
Browse Landscape

Phase

Phase 3 28Phase 2 23Phase NA 3Phase 1 3Phase 1/2 2Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 40Lymphoid 38Myeloid 11Sarcoma 7Plasma cell 6CNS 4Breast 3Dermatologic 2

Conditions

Breast Neoplasms 2Breast Cancer Female 1

Interventions

Paclitaxel 100Trastuzumab 81pembrolizumab 78Fulvestrant 68Cyclophosphamide 66Carboplatin 49Capecitabine 47Docetaxel 45palbociclib 41Lapatinib 40Letrozole 37Doxorubicin 29olaparib 28Taxes 28Nivolumab 25Magnetic Resonance Spectroscopy 25Gemcitabine 25130-nm albumin-bound paclitaxel 25Everolimus 23Biopsy 23ribociclib 22abemaciclib 21Specimen Handling 21Albumin-Bound Paclitaxel 21Cisplatin 20Radiotherapy 19Bevacizumab 19Ado-Trastuzumab Emtansine 19pertuzumab 17Alpelisib 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Methotrexate × Breast × Clear all
NCT02897700 2024-04-17

COC-IDCB

Shanghai Jiao Tong University School of Medicine

Phase 1 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT03518242 2022-06-08

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

Fred Hutchinson Cancer Center

Phase 1 Completed
100 enrolled
Breast

Breast Cancer Female

NCT00496665 2013-11-18

ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

Dana-Farber Cancer Institute

Phase 1 Completed
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡